AIMD Insider Trading

Insider Ownership Percentage: 9.79%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $55,858.90

Ainos Insider Trading History Chart

This chart shows the insider buying and selling history at Ainos by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ainos Share Price & Price History

Current Price: $2.50
Price Change: Price Increase of +0.08 (3.31%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for AIMD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ainos Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/6/2025Carbon Nano Technology TaiwanMajor ShareholderSell7,000$3.59$25,130.001,037,206View SEC Filing Icon  
10/2/2025Carbon Nano Technology TaiwanMajor ShareholderSell2,000$3.58$7,160.001,044,206View SEC Filing Icon  
6/27/2025Chun-Jung TsaiDirectorSell2,000$2.50$5,000.00276,999View SEC Filing Icon  
6/25/2025Chun-Jung TsaiDirectorSell1,400$2.50$3,500.00278,999View SEC Filing Icon  
6/25/2025Ting-Chuan LeeDirectorSell578$2.55$1,473.90285,707View SEC Filing Icon  
6/23/2025Chun-Jung TsaiDirectorSell2,000$2.50$5,000.00280,399View SEC Filing Icon  
6/19/2025Chun-Jung TsaiDirectorSell2,180$2.75$5,995.00282,399View SEC Filing Icon  
6/18/2025Chun-Jung TsaiDirectorSell1,000$2.60$2,600.00284,580View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ainos (NASDAQ:AIMD)

Ainos Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2025Two Sigma Investments LP23,008$80K0.0%N/A0.482%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ainos logo
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.
Read More on Ainos

Today's Range

Now: $2.50
Low: $2.34
High: $2.56

50 Day Range

MA: $3.11
Low: $1.87
High: $4.25

52 Week Range

Now: $2.50
Low: $1.78
High: $5.00

Volume

67,953 shs

Average Volume

41,995 shs

Market Capitalization

$12.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.39

Who are the company insiders with the largest holdings of Ainos?

Ainos' top insider shareholders include:
  1. Carbon Nano Technology Taiwan (Major Shareholder)
  2. Ting-Chuan Lee (Director)
  3. Chun-Jung Tsai (Director)
Learn More about top insider investors at Ainos.

Who are the major institutional investors of Ainos?

Ainos' top institutional shareholders include:
  1. Two Sigma Investments LP — 0.48%
Learn More about top institutional investors of Ainos stock.

Which institutional investors are buying Ainos stock?

During the last quarter, AIMD stock was purchased by institutional investors including:
  1. Two Sigma Investments LP